12 LEXPERT
|
2016
|
WWW.LEXPERT.CA
Cherniawsky, QC, Donald N. Felesky Flynn LLP
(780) 643-3060 dcherniawsky@felesky.com
Mr. Cherniawsky practises in the Edmonton office, focusing on litigation
for matters involving income tax and the GST, as well as on international tax
matters, and corporate and personal tax planning. He has written extensively
on these matters.
Cherney, Richard D. Davies Ward Phillips
& Vineberg LLP (514) 841-6457 rcherney@dwpv.com
Mr. Cherney is a senior partner in the M&A, Capital Markets, Private Equity
practices. From 2000 to 2015 he was a managing partner of Davies.
Richard has represented and continues to represent many of Canada's largest
private and public companies, including some of Canada's most important
financial institutions. He is also a key advisor to many of Canada's leading
life science companies.
Chambers, Gordon R. Cassels Brock & Blackwell LLP
(604) 691-6106 gchambers@casselsbrock.com
Mr. Chambers's securities practice embraces public M&A, public & private
securities offerings, and ongoing disclosure requirements of public companies.
His clients include mining companies, special committees of boards
and dual-listed issuers.
Chamberland, Jean-Pierre Fasken Martineau
DuMoulin LLP (514) 397-5186 jchamberland@fasken.com
Mr. Chamberland is co-head of the Corporate/Commercial section
in the Montréal office. Mr. Chamberland specializes in securities and financing,
mergers and acquisitions, corporate governance and structured products.
He has advised on transactions involving public and private companies
of all sizes and in a wide range of business sectors.
Chaiton, Harvey G. Chaitons LLP
(416) 218-1129 harvey@chaitons.com
Mr. Chaiton's insolvency practice emphasizes domestic and cross-border
receiverships and restructurings, including insolvency litigation. His clients
include financial institutions, creditors, debtors, monitors, receivers
and trustees.
Chadwick, Robert J. Goodmans LLP
(416) 597-4285 rchadwick@goodmans.ca
Mr. Chadwick focuses on corporate, banking, private equity, insolvency
and reorganizations, and M&A law on national, cross-border and international
transactions. He counsels a diverse group of clients, including boards,
in various industries.
LEXPERT RANKED LAWYERS
next annual meeting and replace that board in order to
remove the poison pill.
In Canada, how long a securities commission allows
a poison pill to linger is situation-specific, says Soliman.
"e target must demonstrate that the poison pill con-
tinues to serve a useful purpose in unpacking share-
"Because a Canadian take-over
bid cannot have a financing
condition, you need to be fully
financed as you go in, contrary
to the US, so this forces the
bidder to have a commitment
letter with standby fees out
there for 120 days. There was
concern about the cost of
having financing sitting out
there for a four-month period."
- FRANZISKA RUF,
DAVIES WARD PHILLIPS & VINEBERG LLP
